Nose to Brain Therapeutics LLC is a clinical stage drug development company with a patented-protected treatment for epilepsy. Epilepsy effects over 3.4 million people in the US or about 1.2% of the population. The Nose to Brain Therapeutics LLC treatment will be administered on a daily basis to help reduce the risk and severity of seizures..
Epilepsy
Epilepsy is disorder in which nerve cell activity in the brain is disturbed, causing seizures..Epilepsy may occur as a result of a genetic disorder or an acquired brain injury such as trauma of stroke.
Cannabidiol
Cannabiidiol (CBD) is a natural compound derived from the hemp plant that has shown efficacy in treating Epilepsy when taken orally. But the CBD is prone to negative interactions with other Epilepsy medicines when it is taken this way.
Direct nose-to-brain
Intranasal administration uses a special device to deliver the drug directly to the olfactory region of the nasal cavity and then it passes to the brain. This method minimizes the drug / drug interactions with other epilepsy medicines because it does not go through the GI system, the liver or the blood stream..